A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction
Public ClinicalTrials.gov record NCT06594185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Open Label, Single Arm, Post-Marketing Clinical Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the real-world clinical performance of the enVista Aspire and Aspire Toric intraocular lens (IOL) models EA and ETA and to assess surgeon and subject satisfaction
Study identification
- NCT ID
- NCT06594185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 335 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2024 (Actual)
- Primary completion
- May 21, 2025 (Actual)
- Completion
- May 21, 2025 (Actual)
- Last update posted
- Jun 3, 2026
2024 – 2025
United States locations
- U.S. sites
- 62
- U.S. states
- 25
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 118 | Birmingham | Alabama | 35209 | — |
| Site 154 | Bullhead City | Arizona | 86442 | — |
| Site 137 | Chandler | Arizona | 85224 | — |
| Site 136 | Mesa | Arizona | 85202 | — |
| Site 162 | Phoenix | Arizona | 85028 | — |
| Site 105 | Tucson | Arizona | 85704 | — |
| Site 104 | Bakersfield | California | 93309 | — |
| Site 101 | Beverly Hills | California | 90210 | — |
| Site 151 | Hemet | California | 92543 | — |
| Site 111 | Huntington Beach | California | 92647 | — |
| Site 126 | Long Beach | California | 90805 | — |
| Site 149 | Los Angeles | California | 90024 | — |
| Site 155 | Murrieta | California | 92562 | — |
| Site 109 | Newport Beach | California | 92707 | — |
| Site 112 | Orange | California | 92868 | — |
| Site 144 | Pasadena | California | 91107 | — |
| Site 119 | Torrance | California | 90505 | — |
| Site 115 | Upland | California | 91786 | — |
| Site 161 | Greenwich | Connecticut | 06830 | — |
| Site 130 | Milford | Connecticut | 06460 | — |
| Site 164 | Stamford | Connecticut | 06902 | — |
| Site 125 | Bradenton | Florida | 34209 | — |
| Site 148 | Mt. Dora | Florida | 32757 | — |
| Site 143 | Pompano Beach | Florida | 33064 | — |
| Site 127 | Tarpon Springs | Florida | 34689 | — |
| Site 153 | Winter Park | Florida | 32792 | — |
| Site134 | Gainesville | Georgia | 30501 | — |
| Site 165 | Roswell | Georgia | 30076 | — |
| Site 163 | Honolulu | Hawaii | 96813 | — |
| Site 160 | Honolulu | Hawaii | 96814 | — |
| Site 108 | Rock Island | Illinois | 61201 | — |
| Site 133 | Shreveport | Louisiana | 71103 | — |
| Site 131 | Birmingham | Michigan | 48009 | — |
| Site 121 | Alexandria | Minnesota | 56308 | — |
| Site 142 | Alexandria | Minnesota | 56308 | — |
| Site 102 | Bloomington | Minnesota | 55420 | — |
| Site 106 | Kansas City | Missouri | 64133 | — |
| Site 128 | Bozeman | Montana | 59718 | — |
| Site 117 | South Sioux City | Nebraska | 68776 | — |
| Site 114 | South Orange | New Jersey | 07079 | — |
| Site 159 | Albuquerque | New Mexico | 87109 | — |
| Site132 | Poughkeepsie | New York | 12603 | — |
| Site 138 | Goldsboro | North Carolina | 27534 | — |
| Site 156 | Leland | North Carolina | 28451 | — |
| Site 107 | West Fargo | North Dakota | 58078 | — |
| Site 103 | Brecksville | Ohio | 44142 | — |
| Site 129 | Cincinnati | Ohio | 45242 | — |
| Site 166 | Moore | Oklahoma | 73160 | — |
| Site 152 | Bend | Oregon | 97701 | — |
| Site 135 | Medford | Oregon | 97504 | — |
| Site 150 | Allenwood | Pennsylvania | 17810 | — |
| Site 140 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Site 157 | Kingston | Pennsylvania | 18704 | — |
| Site 145 | Austin | Texas | 78704 | — |
| Site 158 | Austin | Texas | 78731 | — |
| Site 113 | Beaumont | Texas | 77707 | — |
| Site 110 | Dallas | Texas | 75243 | — |
| Site 147 | Houston | Texas | 77008 | — |
| Site 141 | Houston | Texas | 77055 | — |
| Site 123 | San Antonio | Texas | 78209 | — |
| Site 124 | San Antonio | Texas | 78229 | — |
| Site 122 | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06594185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2026 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06594185 live on ClinicalTrials.gov.